Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer

Title
Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 58, Issue 12, Pages 4883-4887
Publisher
American Chemical Society (ACS)
Online
2015-06-03
DOI
10.1021/acs.jmedchem.5b00760

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now